Alpenglow Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.8M

  • Investors
  • 12

Alpenglow Biosciences General Information

Description

Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples. The company's system leverages proprietary three-dimensional scanning microscopes and artificial intelligence (AI) algorithms to provide spatial biology insights with proprietary sample preparation, light-sheet microscopy, cloud-based data processing and storage, three-dimensional (3D) visualization and AI analysis, enabling healthcare companies to accelerate drug development and improve clinical diagnostics.

Contact Information

Formerly Known As
Lightspeed Microscopy
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2121 North 35th Street
  • Suite 100
  • Seattle, WA 98103
  • United States
+1 (206)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Corporate Office
  • 2121 North 35th Street
  • Suite 100
  • Seattle, WA 98103
  • United States
+1 (206)

Alpenglow Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alpenglow Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 31-Dec-2025 $4.8M Completed Generating Revenue
11. Later Stage VC 24-Apr-2024 Completed Generating Revenue
10. Grant 01-Aug-2023 Completed Generating Revenue
9. Grant 31-Aug-2022 Completed Generating Revenue
8. Grant 30-Jun-2022 Completed Generating Revenue
7. Grant 01-Apr-2022 Completed Generating Revenue
6. Early Stage VC (Series A) 22-Jun-2021 Completed Generating Revenue
5. Accelerator/Incubator Completed Startup
4. Grant 05-Sep-2020 $398K $400K Completed Startup
3. Early Stage VC 10-Sep-2019 $400K $400K Completed Startup
To view Alpenglow Biosciences’s complete valuation and funding history, request access »

Alpenglow Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Alpenglow Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Alpenglow Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue sa
Discovery Tools (Healthcare)
Seattle, WA
29 As of 2026

Hampton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alpenglow Biosciences Competitors (1)

One of Alpenglow Biosciences’s competitors is Visikol, a Formerly VC-backed company based in Hampton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Visikol Formerly VC-backed Hampton, NJ
You’re viewing 1 of 1 competitors. Get the full list »

Alpenglow Biosciences Patents

Alpenglow Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4602638-A1 Apparatuses, systems, and methods for processing of three dimensional optical microscopy image data Pending 14-Oct-2022
EP-4602638-A4 Apparatuses, systems, and methods for processing of three dimensional optical microscopy image data Pending 14-Oct-2022
US-20250265851-A1 Apparatuses, systems, and methods for processing of three dimensional optical microscopy image data Pending 14-Oct-2022
WO-2024081816-A1 Apparatuses, systems, and methods for processing of three dimensional optical microscopy image data Inactive 14-Oct-2022 G06V20/695

Alpenglow Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alpenglow Biosciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andy Hill Care Fund Government
National Institutes of Health Government
U.S. Department of Health and Human Services Government
Alexandria Real Estate Equities Real Estate Minority
Dynamk Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Alpenglow Biosciences FAQs

  • When was Alpenglow Biosciences founded?

    Alpenglow Biosciences was founded in 2018.

  • Where is Alpenglow Biosciences headquartered?

    Alpenglow Biosciences is headquartered in Seattle, WA.

  • What is the size of Alpenglow Biosciences?

    Alpenglow Biosciences has 29 total employees.

  • What industry is Alpenglow Biosciences in?

    Alpenglow Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is Alpenglow Biosciences a private or public company?

    Alpenglow Biosciences is a Private company.

  • What is Alpenglow Biosciences’s current revenue?

    The current revenue for Alpenglow Biosciences is .

  • How much funding has Alpenglow Biosciences raised over time?

    Alpenglow Biosciences has raised $9.8M.

  • Who are Alpenglow Biosciences’s investors?

    Andy Hill Care Fund, National Institutes of Health, U.S. Department of Health and Human Services, Alexandria Real Estate Equities, and Dynamk Capital are 5 of 12 investors who have invested in Alpenglow Biosciences.

  • Who are Alpenglow Biosciences’s competitors?

    Visikol is a competitor of Alpenglow Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process